Skip to main content
Press

ISR Identifies Patterns of Unmet Needs amongst Autoimmune Disease Patients

By December 20th, 2021No Comments

Informing the pharmaceutical drug development and commercialization industry.

Cary, N.C. – January 7, 2013 – Industry Standard Research (ISR) has announced the release of a new market research report entitled “Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment.” This report surveyed 208 US-based patients with an autoimmune disease to identify patterns and preferences surrounding the needs, treatments, and side-effects of patients living with these conditions.

“This report provides novel, on-the-ground insights into the patient condition, as well as patterns of unmet needs that correlate to patients’ social status, family history, diagnosis pathway, and treatment experience,” explained Andrew Schafer, President of ISR. “For drug manufacturers, this report represents an opportunity to better understand the challenges their patients face and enhance development and commercial activities to address the unmet needs of their patients.”

ISR’s report surveyed 208 US-based patients with one of the following autoimmune diseases: Celiac disease, Fibromyalgia, Graves’ disease, Hashimoto’s disease, Lupus, Multiple Sclerosis, Rheumatoid Arthritis, or Ulcerative Colitis. When applicable, ISR presents data regarding statistically significant differences between demographic segments. These segments were defined as: condition, insurance coverage, likelihood to enroll in a clinical trial, primary treating physician, time since diagnosis, and severity of symptoms.

With ISR’s report you’ll learn:

  • The prevalence of symptoms associated with each disease and which symptoms cause the most difficulty
  • Patient satisfaction with their current abilities, the occurrence of pain, and how the disease affects everyday life
  • How a patient’s socio-economic status and level of satisfaction with their condition/ treatment regimen affect their willingness to enroll in a clinical trial
  • Trends in disease diagnosis
  • Payment issues with insurance
  • Patient interactions with physicians (PCPs and Specialists) and the non-medical individuals they turn to the most for support

For more information about ISR’s “Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment” report, including the ability to download a free report preview, please visit ISR’s web site at https://isrreports.com/reports/autoimmune-diseases-current-treatments-unmet-needs-and-patient-recruitment/.

About Industry Standard Research

Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience, ISR delivers an unmatched level of domain expertise.  For more information about our off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on Twitter @ISRreports.